-
Free Guide: A Guide to Making Your Will
… Free Guide: A Guide to Making Your Will Fill out the below form for access to our comprehensive guide on how to make your will. First Name Last Name Email ZIP code …
-
Financial Times: Actor's Charity to Back Swiss Drug Trial
September 8, 2010
… has received funding from MJFF for a clinical trial to test a potential therapy for dyskinesias, a major priority research area for MJFF. The therapy targets a receptor in the brain called mGluR5, a promising … the Phase II study. MJFF has supported approximately 90 companies to date who develop therapies that address the …
-
Sharing the Wealth: A Couple Dedicated to Parkinson's Disease Research and Advocacy
October 31, 2013
… in research or promoting research… it’s like being able to harvest 10% of the placebo effect. It really can add some … health histories. The more familial information researchers get, it the more knowledge they have to help identify … a guest blogger for FoxFeed and profiles members of the PD community who have participated in clinical trials when …
-
How Scientists Can Serve the Patient Community Outside of the Lab
July 18, 2016
… myself who is pursuing a non-traditional career in science communications, I was so pleased to read my colleague's personal story on how she also transitioned from the lab to work at the The …
-
How Broadway Dance Class Helped Me Have a Great Day with Parkinson's
September 11, 2014
… Rockyettes Group Photo 2014 (I'm in the 2nd row at the 1st position on the far … day was that my voice worked almost all day. I was able to communicate with the dancers and talk to members of the … tried to cover it up, and said it was a terrible day. However, when my right hand shook at a recent performance, I …
-
Patient Advocacy Keeps Antidepressants Accessible to People with Parkinson's Disease
March 13, 2014
… announced it would not pursue a controversial proposal to remove antidepressants as a “protected class” under … worked with Congress and CMS to raise awareness of the negative impacts this policy would have on patients. … have limited access to the medications needed to treat a common co-morbidity of Parkinson's disease.” Read more about …